The complex role of Gαs in cancer biology is further highlighted by the reality that LOF mutations or deletions of Gαs may expedite tumor initiation and progression by de‐repressing critical oncogenic pathways, including the Hippo signaling pathway and Sonic Hh [160, 161]. This evidence concerns the gene GAST and neoplasm.